Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
182K
-
Shares change
-
-17.8K
-
Total reported value, excl. options
-
$31.3M
-
Value change
-
-$3.02M
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$172.02
Significant Holders of RESMED INC - COM (RMD) as of Q4 2023
9 filings reported holding RMD - RESMED INC - COM as of Q4 2023.
RESMED INC - COM (RMD) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 182K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (17.7M shares), BlackRock Inc. (12.2M shares), STATE STREET CORP (6.29M shares), GEODE CAPITAL MANAGEMENT, LLC (3.44M shares), FMR LLC (2.53M shares), Invesco Ltd. (1.95M shares), MORGAN STANLEY (1.74M shares), NORTHERN TRUST CORP (1.45M shares), NORGES BANK (1.36M shares), and Bank of New York Mellon Corp (1.15M shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.